Spectral endoscopy enhances contrast for neoplasia in surveillance of barrett's esophagus by Waterhouse, DJ, Januszewicz, W, Ali, S, Fitzgerald, RC, di Pietro, M, Bohndiek, SE

Characterization of the selective indoleamine 2,3-dioxygenase-1 (IDO1) catalytic inhibitor EOS200271/PF-06840003 supports IDO1 as a critical resistance mechanism to PD-(L)1 blockad... by Gomes, B, Driessens, G, Bartlett, D, Cai, D, Cauwenberghs, S, Crosignani, S, Dalvie, D, Denies, S, Dillon, C, Fantin, V, Guo, J, Letellier, M, Li, W, Maegley, K, Marillier, R, Miller, N, Pirson, R, Rabolli, V, Ray, C, Streiner, N, Torti, V, Tsaparikos, K, Van Den Eynde, B, Wythes, M, Yao, L, Zheng, X, Tumang, J, Kraus, M

Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium by Ose, J, Poole, E, Schock, H, Lehtinen, M, Arslan, A, Zeleniuch-Jacquotte, A, Visvanathan, K, Helzlsouer, K, Buring, J, Lee, I, Tjønneland, A, Dossus, L, Trichopoulou, A, Masala, G, Onland-Moret, N, Weiderpass, E, Duell, E, Idahl, A, Travis, R, Rinaldi, S, Merritt, M, Trabert, B, Wentzensen, N, Tworoger, S, Kaaks, R, Fortner, R

A functional genomic screen identifies the deubiquitinase USP11 as a novel transcriptional regulator of ERα in breast cancer by Dwane, L, O'Connor, AE, Das, S, Moran, B, Mulrane, L, Pinto-Fernandez, A, Ward, E, Blümel, AM, Cavanagh, BL, Mooney, B, Dirac, AM, Jirström, K, Kessler, BM, Ní Chonghaile, T, Bernards, R, Gallagher, WM, O'Connor, DP

Dsh homolog DVL3 mediates resistance to IGFIR inhibition by regulating IGF-RAS signaling. by Gao, S, Bajrami, I, Verrill, C, Kigozi, A, Ouaret, D, Aleksic, T, Asher, R, Han, C, Allen, P, Bailey, D, Feller, S, Kashima, T, Athanasou, N, Blay, J, Schmitz, S, Machiels, J, Upile, N, Jones, T, Thalmann, G, Ashraf, S, Wilding, J, Bodmer, W, Middleton, MR, Ashworth, A, Lord, C

Metastasis and immune evasion from extracellular cGAMP hydrolysis by Li, J, Duran, MA, Dhanota, N, Chatila, WK, Bettigole, SE, Kwon, J, Sriram, RK, Humphries, MP, Salto-Tellez, M, James, JA, Hanna, MG, Melms, JC, Vallabhaneni, S, Litchfield, K, Usaite, I, Biswas, D, Bareja, R, Li, HW, Martin, ML, Dorsaint, P, Cavallo, J-A, Li, P, Pauli, C, Gottesdiener, L, DiPardo, BJ, Hollmann, TJ, Merghoub, T, Wen, HY, Reis-Filho, JS, Riaz, N, Su, S-SM, Kalbasi, A, Vasan, N, Powell, SN, Wolchok, JD, Elemento, O, Swanton, C, Shoushtari, AN, Izar, B, Parkes, EE, Bakhoum, SF

Insulin-like growth factor-i and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition. by Schmidt, J, Allen, N, Almquist, M, Franceschi, S, Rinaldi, S, Tipper, S, Tsilidis, K, Weiderpass, E, Overvad, K, Tjønneland, A, Boutron-Ruault, M, Dossus, L, Mesrine, S, Kaaks, R, Lukanova, A, Boeing, H, Lagiou, P, Trichopoulos, D, Trichopoulou, A, Palli, D, Krogh, V, Panico, S, Tumino, R, Zanetti, R, Bueno-de-Mesquita, H

Regulation of hepatocyte growth factor activator inhibitor 2 by hypoxia in breast cancer by Generali, D, Fox, S, Berruti, A, Moore, J, Brizzi, M, Patel, N, Allevi, G, Bonardi, S, Aguggini, S, Bersiga, A, Campo, L, Dogliotti, L, Bottini, A, Harris, A

“…. © 2007 American Association for Cancer Research.…”

The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European prospective investigation into cancer and nutrition by Crowe, F, Key, T, Allen, N, Appleby, P, Roddam, A, Overvad, K, Grønbæk, H, Tjønneland, A, Halkjær, J, Dossus, L, Boeing, H, Kröger, J, Trichopoulou, A, Dilis, V, Trichopoulos, D, Boutron-Ruault, M, De Lauzon, B, Clavel-Chapelon, F, Palli, D, Berrino, F, Panico, S, Tumino, R, Sacerdote, C, Bueno-de-Mesquita, H, Vrieling, A

“…Copyright © 2009 American Association for Cancer Research.…”

VCAM-1 targeted magnetic resonance imaging enables detection of brain micrometastases from different primary tumours by Cheng, VWT, Soto, M, Khrapitchev, A, Balderas, F, Zakaria, R, Jenkinson, MD, Middleton, MR, Sibson, N

The Oxford Classic links epithelial-mesenchymal transition to immunosuppression in poor prognosis ovarian cancers by Hu, Z, Cunnea, P, Zhong, Z, Lu, H, Osagie, OI, Campo, L, Artibani, M, Nixon, K, Ploski, J, Gonzalez, LS, Alsaadi, A, Wietek, N, Damato, S, Dhar, S, Blagden, S, Yau, C, Hester, J, Albukhari, A, Aboagye, EO, Fotopoulou, C, Ahmed, A

A genetic risk score to personalize prostate cancer screening, applied to population data by Huynh-Le, M-P, Fan, CC, Karunamuni, R, Neal, DE, Hamdy, FC, Key, TJ, Travis, RC, Mills, IG, Et al.

Radiosensitation in vivo by histone deacetylase inhibition with no increase in early normal tissue radiation toxicity by Groselj, B, Ruan, J, Scott, H, Gorrill, J, Nicholson, J, Kelly, J, Anbalagan, S, Thompson, J, Stratford, M, Jevons, S, Hammond, E, Scudamore, C, Kerr, M, Kiltie, A

A novel carcinoembryonic antigen t cell bispecific antibody (cea tcb) for the treatment of solid tumors by Bacac, M, Fauti, T, Sam, J, Colombetti, S, Weinzierl, T, Ouaret, D, Bodmer, W, Lehmann, S, Hofer, T, Hosse, R, Moessner, E, Ast, O, Bruenker, P, Grau-Richards, S, Schaller, T, Seidl, A, Gerdes, C, Perro, M, Nicolini, V, Steinhoff, N, Dudal, S, Neumann, S, von Hirschheydt, T, Jaeger, C, Saro, J, Karanikas, V, Klein, C, Umana, P

Development of therapeutic anti-JAGGED1 antibodies for cancer therapy by Masiero, M, Li, D, Whiteman, P, Bentley, C, Greig, J, Hassanali, T, Watts, S, Stribbling, S, Yates, J, Bealing, E, Li, J-L, Chillakuri, C, Sheppard, D, Serres, S, Sarmiento-Soto, M, Larkin, J, Sibson, NR, Handford, PA, Harris, AL, Banham, AH

A meta-analysis of individual participant data reveals an association between circulating levels of IGF-I and prostate cancer risk by Travis, R, Appleby, P, Price, A, Key, T, Hamdy, F, Allen, N, Endogenous Hormones, Nutritional Biomarkers and Prostate Cancer Collaborative Group

Constitutive IDO1 expression in human tumors is driven by cyclooxygenase-2 and mediates intrinsic immune resistance. by Hennequart, M, Pilotte, L, Cane, S, Hoffmann, D, Stroobant, V, Plaen, E, Van den Eynde, B

Mitochondrial DNA copy number variation and pancreatic cancer risk in the prospective EPIC cohort by Gentiluomo, M, Katzke, V, Kaaks, R, Schmidt, J, Et al.

Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression, and drug response by Zhang, P, Kitchen-Smith, I, Xiong, L, Stracquadanio, G, Brown, K, Richter, PH, Wallace, MD, Bond, E, Sahgal, N, Moore, S, Nornes, S, De Val, S, Surakhy, M, Sims, D, Wang, X, Bell, DA, Zeron-Medina, J, Jiang, Y, Ryan, AJ, Selfe, JL, Shipley, J, Kar, S, Pharoah, PDP, Loveday, C, Jansen, R, Grochola, LF, Palles, C, Protheroe, A, Millar, V, Ebner, DV, Pagadala, M, Blagden, SP, Maughan, TS, Domingo, E, Tomlinson, I, Turnbull, C, Carter, H, Bond, GL

Attenuating adaptive VEGF-A and IL-8 signaling restores durable tumor control in AR-antagonist-treated prostate cancers by Maxwell, PJ, McKechnie, M, Armstrong, CW, Manley, JM, Ong, CW, Worthington, J, Mills, IG, Longley, DB, Quigley, JP, Zoubedi, A, de Bono, JS, Deryugina, E, LaBonte, MJ, Waugh, DJJ